Menu Search
Equities

Stevanato Group SpA

STVN:NYQ

Stevanato Group SpA

Actions
Health CareMedical Equipment and Services
  • Price (USD)19.98
  • Today's Change0.36 / 1.83%
  • Shares traded41.75k
  • 1 Year change-28.03%
  • Beta0.5859
Data delayed at least 15 minutes, as of Nov 22 2024 15:18 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy4
Outperform3
Hold3
Sell0
Strong Sell0

Share price forecast in EUR

The 9 analysts offering 12 month price targets for Stevanato Group SpA have a median target of 24.09, with a high estimate of 36.76 and a low estimate of 20.87. The median estimate represents a 22.79% increase from the last price of 19.62.
High87.3%36.76
Med22.8%24.09
Low6.3%20.87

Dividends in EUR

In 2023, Stevanato Group SpA reported a dividend of 0.05 EUR, which represents a 5.88% increase over last year. The 4 analysts covering the company expect dividends of 0.05 EUR for the upcoming fiscal year, a decrease of 7.41%.
Div growth (TTM)5.88%
More ▼

Earnings history & estimates in EUR

On Nov 05, 2024, Stevanato Group SpA reported 3rd quarter 2024 earnings of 0.12 per share. This result was in line with the consensus of the 9 analysts following the company and under-performed last year's 3rd quarter results by 20.00%.
The next earnings announcement is expected on Mar 06, 2025.
Average growth rate+2.57%
Stevanato Group SpA reported annual 2023 earnings of 0.58 per share on Mar 07, 2024.
Average growth rate+9.95%
More ▼

Revenue history & estimates in EUR

Stevanato Group SpA had 3rd quarter 2024 revenues of 277.90m. This bettered the 274.37m consensus of the 8 analysts covering the company. This was 16.76% above the prior year's 3rd quarter results.
Average growth rate+2.20%
Stevanato Group SpA had revenues for the full year 2023 of 1.09bn. This was 10.34% above the prior year's results.
Average growth rate+13.45%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.